Gedeon Richter in Poland

share price:

10430

Gedeon Richter is a specialised, innovation-driven pharmaceutical company committed to supporting society in the fight against disease by developing and delivering modern therapies.

Learn more

A specialised pharmaceutical company
Gedeon Richter’s strategic objective is to strengthen its position among Europe’s leading mid-sized pharmaceutical companies.

Areas of Expertise

Areas of Activity

Gedeon Richter focuses on creating high value-added products, basing its strategy on innovative research and placing a strong emphasis on women’s health and the development of biosimilar medicines.

Learn more

Research into new molecules has always been at the core of Gedeon Richter’s corporate strategy. The company’s research and development centre, employing more than 1,200 people, makes it the leading pharmaceutical research hub in Central and Eastern Europe.

Our Products

Gedeon Richter’s portfolio includes over 200 original, generic and licensed therapies used across a wide range of therapeutic areas. The company focuses on developing and manufacturing medicines used in the treatment of disorders of the nervous system, cardiovascular diseases and gynaecology.

Learn more

Thanks to its in-house production of active pharmaceutical ingredients and a broad product portfolio, Richter delivers innovative therapeutic solutions for women of all ages and   with diverse health needs.

Sustainability

At Gedeon Richter, we continuously pursue innovation. At the same time, we believe that through conscious and responsible actions, we can meet the needs of today’s generations while maintaining the trust of those to come.

Learn more

We are proud that Gedeon Richter represents not only innovative products, but also a stable and supportive workplace guided by the principles of sustainable development.

Contact

If you have any questions, please contact us using the appropriate telephone number or email address.

If you have not found the information you were looking for on our website or have additional questions, we encourage you to get in touch with us.

About us Gedeon Richter in Poland Strategy Operations Our History Initiatives News European Funds Downloads

Gedeon Richter Polska is part of an international specialised pharmaceutical company that develops its operations on five continents.

The company aspires to become a global innovator across several key scientific fields, while actively working to improve access to medicines worldwide. In 2024, Gedeon Richter’s market capitalisation amounted to EUR 4.7 billion, with sales reaching EUR 2.2 billion. Gedeon Richter operates the largest research and development centre in Central Europe, delivering breakthrough solutions in neuropsychiatry and women’s healthcare. The company’s biotechnology operations and its generic medicines portfolio contribute to improving patient access to therapies. Gedeon Richter also manufactures active pharmaceutical ingredients, including those that are used in the production of its own products. Committed to sustainable growth, Gedeon Richter invests in research and development, manufacturing excellence and digitalisation to drive medical innovation.

Gedeon Richter has operated on the Polish market since 1994. The company is headquartered in Grodzisk Mazowiecki, home to its manufacturing facility, logistics, head office and administrative infrastructure, as well as one of Gedeon Richter Group’s largest research bases in Central and Eastern Europe. The company operates its marketing and sales office in Warsaw, and maintains an extensive network of sales representatives across the entire country.

Today, Poland is one of Gedeon Richter’s key markets, with products manufactured locally reaching both domestic and international markets. Thanks to consistent investment, the manufacturing facility in Grodzisk Mazowiecki has expanded its capacity, now producing around one billion tablets annually while meeting the highest manufacturing standards. The therapies produced in Grodzisk Mazowiecki include treatments that are of key importance to patients in Poland. The facility manufactures medicines used in cardiology and circulatory system disorders, neurology and central nervous system diseases, as well as immunostimulatory drugs.

Gedeon Richter is currently undertaking its largest-ever investment in Poland: the expansion of its manufacturing facility in Grodzisk Mazowiecki. Its aim is to expand the existing manufacturing facility and boost our production capabilities by as much as 350 million tablets per year.

Management Board of Gedeon Richter Polska Sp. z o.o.

Németh Tomasz

President of the Management Board, Chief Executive Officer

President of the Management Board and CEO of Gedeon Richter Polska Sp. z o.o., Tomasz is an economist holding an MBA from the University of Illinois. He started his career in the banking industry.

Mariusz Mańkowski

Member of the Management Board, Director of Production and Logistics

Mariusz holds a degree from the Medical University of Warsaw, Faculty of Pharmacy, as well as postgraduate qualifications from Kozminski University (EMBA) and the Warsaw School of Management and Marketing.